MicroRNA Regulation in Systemic Lupus Erythematosus Pathogenesis |
Yan, Sheng
(Department of Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong)
Yim, Lok Yan (Department of Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong) Lu, Liwei (Department of Pathology, Li Ka Shing Faculty of Medicine, The University of Hong Kong) Lau, Chak Sing (Department of Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong) Chan, Vera Sau-Fong (Department of Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong) |
1 | Wang, H., W. Peng, X. Ouyang, W. Li, and Y. Dai. 2012. Circulating microRNAs as candidate biomarkers in patients with systemic lupus erythematosus. Transl. Res. 160: 198-206. DOI ScienceOn |
2 |
Fontenot, J. D., M. A. Gavin, and A. Y. Rudensky. 2003. Foxp3 programs the development and function of |
3 | Divekar, A. A., S. Dubey, P. R. Gangalum, and R. R. Singh. 2011. Dicer insufficiency and microRNA-155 overexpression in lupus regulatory T cells: an apparent paradox in the setting of an inflammatory milieu. J. Immunol. 186: 924-930. DOI ScienceOn |
4 | Xu, S., K. Guo, Q. Zeng, J. Huo, and K. P. Lam. 2012. The RNase III enzyme Dicer is essential for germinal center B-cell formation. Blood 119: 767-776. DOI ScienceOn |
5 | Ademokun, A. and M. Turner. 2008. Regulation of B-cell differentiation by microRNAs and RNA-binding proteins. Biochem. Soc. Trans. 36: 1191-1193. DOI ScienceOn |
6 | Koralov, S. B., S. A. Muljo, G. R. Galler, A. Krek, T. Chakraborty, C. Kanellopoulou, K. Jensen, B. S. Cobb, M. Merkenschlager, N. Rajewsky, and K. Rajewsky. 2008. Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage. Cell 132: 860-874. DOI ScienceOn |
7 | Wiesen, J. L., and T. B. Tomasi. 2009. Dicer is regulated by cellular stresses and interferons. Mol. Immunol. 46: 1222-1228. DOI ScienceOn |
8 | Satoh, M., J. Y. F. Chan, A. Ceribelli, M. Vazquez del-Mercado, and E. K. Chan. 2013. Autoantibodies to Argonaute 2 (Su antigen). Adv. Exp. Med. Biol. 768: 45-59. DOI ScienceOn |
9 | Jakymiw, A., K. Ikeda, M. J. Fritzler, W. H. Reeves, M. Satoh, and E. K. Chan. 2006. Autoimmune targeting of key components of RNA interference. Arthritis Res. Ther. 8: R87. DOI ScienceOn |
10 | Lu, J., G. Getz, E. A. Miska, E. Alvarez-Saavedra, J. Lamb, D. Peck, A. Sweet-Cordero, B. L. Ebert, R. H. Mak, A. A. Ferrando, J. R. Downing, T. Jacks, H. R. Horvitz, and T. R. Golub. 2005. MicroRNA expression profiles classify human cancers. Nature 435: 834-838. DOI ScienceOn |
11 | Zhu, S., W. Pan, and Y. Qian. 2013. MicroRNA in immunity and autoimmunity. J. Mol. Med. (Berl). 91: 1039-1050. DOI ScienceOn |
12 | Miao, C. G., Y. Y. Yang, X. He, C. Huang, Y. Huang, L. Zhang, X. W. Lv, Y. Jin, and J. Li. 2013. The emerging role of microRNAs in the pathogenesis of systemic lupus erythematosus. Cell. Signal. 25: 1828-1836. DOI ScienceOn |
13 | Muljo, S. A., K. M. Ansel, C. Kanellopoulou, D. M. Livingston, A. Rao, and K. Rajewsky. 2005. Aberrant T cell differentiation in the absence of Dicer. J. Exp. Med. 202: 261-269. DOI ScienceOn |
14 | Gregory, R. I., K. P. Yan, G. Amuthan, T. Chendrimada, B. Doratotaj, N. Cooch, and R. Shiekhattar. 2004. The Microprocessor complex mediates the genesis of microRNAs. Nature 432: 235-240. DOI ScienceOn |
15 | Lund, E., S. Guttinger, A. Calado, J. E. Dahlberg, and U. Kutay. 2004. Nuclear export of microRNA precursors. Science 303: 95-98. DOI ScienceOn |
16 | Bartel, D. P. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297. DOI ScienceOn |
17 | Chong, M. M., J. P. Rasmussen, A. Y. Rundensky, and D. R. Littman. 2008. The RNAseIII enzyme Drosha is critical in T cells for preventing lethal inflammatory disease. J. Exp. Med. 205: 2005-2017. DOI ScienceOn |
18 | Cobb, B. S., T. B. Nesterova, E. Thompson, A. Hertweck, E. O'Connor, J. Godwin, C. B. Wilson, N. Brockdorff, A. G. Fisher, S. T. Smale, and M. Merkenschlager. 2005. T cell lineage choice and differentiation in the absence of the RNase III enzyme Dicer. J. Exp. Med. 201: 1367-1373. DOI ScienceOn |
19 | Liston, A., L. F. Lu, D. O'Carroll, A. Tarakhovsky, and A. Y. Rudensky. 2008. Dicer-dependent microRNA pathway safeguards regulatory T cell function. J. Exp. Med. 205: 1993-2004. DOI ScienceOn |
20 | Bartel, D. P. 2009. MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233. DOI ScienceOn |
21 | Chen, C. Z., I. Li, H. F. Lodish, and D. P. Bartel. 2004. MicroRNAs modulate hematopoietic lineage differentiation. Science 303: 83-86. DOI ScienceOn |
22 | Carrington, J. C. and V. Ambros. 2003. Role of microRNAs in plant and animal development. Science 301: 336-338. DOI ScienceOn |
23 | Baltimore, D., M. P. Boldin, R. M. O'Connell, D. S. Rao, and K. D. Taganov. 2008. MicroRNAs: new regulators of immune cell development and function. Nat. Immunol. 9: 839-845. DOI ScienceOn |
24 | Carthew, R. W. and E. J. Sontheimer. 2009. Origins and Mechanisms of miRNAs and siRNAs. Cell 136: 642-655. DOI ScienceOn |
25 | O'Connell, R. M., D. S. Rao, A. A. Chaudhuri, and D. Baltimore. 2010. Physiological and pathological roles for microRNAs in the immune system. Nat. Rev. Immunol. 10: 111-122. DOI ScienceOn |
26 | Asirvatham, A. J., C. J. Gregorie, Z. Hu, W. J. Magner, and T. B. Tomasi. 2008. MicroRNA targets in immune genes and the Dicer/Argonaute and ARE machinery components. Mol. Immunol. 45: 1995-2006. DOI ScienceOn |
27 | Mak, A., D. A. Isenberg, and C. S. Lau. 2013. Global trends, potential mechanisms and early detection of organ damage in SLE. Nat. Rev. Rheumatol. 9: 301-310. |
28 | Kim, V. N., J. Han, and M. C. Siomi. 2009. Biogenesis of small RNAs in animals. Nat. Rev. Mol. Cell Biol. 10: 126-139. DOI ScienceOn |
29 | Tsokos, G. C. 2011. Systemic lupus erythematosus. N. Engl. J. Med. 365: 2110-2121. DOI ScienceOn |
30 | Luo, X., L. M. Tsai, N. Shen, and D. Yu. 2010. Evidence for microRNA-mediated regulation in rheumatic diseases. Ann. Rheum. Dis. 69 Suppl 1: i30-36. DOI ScienceOn |
31 | Bennett, L., A. K. Palucka, E. Arce, V. Cantrell, J. Borvak, J. Banchereau, and V. Pascual. 2003. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J. Exp. Med. 197: 711-723. DOI ScienceOn |
32 | Obermoser, G. and V. Pascual. 2010. The interferon-alpha signature of systemic lupus erythematosus. Lupus 19: 1012-1019. DOI ScienceOn |
33 | Luo, X., L. Zhang, M. Li, W. Zhang, X. Leng, F. Zhang, Y. Zhao, and X. Zeng. 2013. The role of miR-125b in T lymphocytes in the pathogenesis of systemic lupus erythematosus. Clin. Exp. Rheumatol. 31: 263-271. |
34 | Lu, M. C., N. S. Lai, H. C. Chen, H. C. Yu, K. Y. Huang, C. H. Tung, H. B. Huang, and C. L. Yu. 2013. Decreased microRNA(miR)-145 and increased miR-224 expression in T cells from patients with systemic lupus erythematosus involved in lupus immunopathogenesis. Clin. Exp. Immunol. 171: 91-99. DOI ScienceOn |
35 | Inui, M., G. Martello, and S. Piccolo. 2010. MicroRNA control of signal transduction. Nat. Rev. Mol. Cell Biol. 11: 252-263. DOI ScienceOn |
36 |
Zhao, S., Y. Wang, Y. Liang, M. Zhao, H. Long, S. Ding, H. Yin, and Q. Lu. 2011. MicroRNA-126 regulates DNA methylation in |
37 | Stagakis, E., G. Bertsias, P. Verginis, M. Nakou, M. Hatziapostolou, H. Kritikos, D. Iliopoulos, and D. T. Boumpas. 2011. Identification of novel microRNA signatures linked to human lupus disease activity and pathogenesis: miR-21 regulates aberrant T cell responses through regulation of PDCD4 expression. Ann. Rheum. Dis. 70: 1496-1506. DOI ScienceOn |
38 |
Pan, W., S. Zhu, M. Yuan, H. Cui, L. Wang, X. Luo, J. Li, H. Zhou, Y. Tang, and N. Shen. 2010. MicroRNA-21 and microRNA-148a contribute to DNA hypomethylation in lupus |
39 | Alcocer-Varela, J. and D. Alarcon-Segovia. 1982. Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus. J. Clin. Invest. 69: 1388-1392. DOI |
40 | Boyman, O. and J. Sprent. 2012. The role of interleukin-2 during homeostasis and activation of the immune system. Nat. Rev. Immunol. 12: 180-190. |
41 | Fan, W., D. Liang, Y. Tang, B. Qu, H. Cui, X. Luo, X. Huang, S. Chen, B. W. Higgs, B. Jallal, Y. Yao, J. B. Harley, and N. Shen. 2012. Identification of microRNA-31 as a novel regulator contributing to impaired interleukin-2 production in T cells from patients with systemic lupus erythematosus. Arthritis Rheum. 64: 3715-3725. DOI ScienceOn |
42 | Carlsen, A. L., A. J. Schetter, C. T. Nielsen, C. Lood, S. Knudsen, A. Voss, C. C. Harris, T. Hellmark, M. Segelmark, S. Jacobsen, A. A. Bengtsson, and N. H. Heegaard. 2013. Circulating microRNA expression profiles associated with systemic lupus erythematosus. Arthritis Rheum. 65: 1324-1334. DOI ScienceOn |
43 |
Zhang, Y., M. Zhao, A. H. Sawalha, B. Richardson, and Q. Lu. 2013. Impaired DNA methylation and its mechanisms in |
44 | Tang, Y., X. Luo, H. Cui, X. Ni, M. Yuan, Y. Guo, X. Huang, H. Zhou, N. de Vries, P. P. Tak, S. Chen, and N. Shen. 2009. MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum. 60: 1065-1075. DOI ScienceOn |
45 | Te, J. L., I. M. Dozmorov, J. M. Guthridge, K. L. Nguyen, J. W. Cavett, J. A. Kelly, G. R. Bruner, J. B. Harley, and J. O. Ojwang. 2010. Identification of unique microRNA signature associated with lupus nephritis. PLoS One 5: e10344. DOI ScienceOn |
46 | Baechler, E. C., F. M. Batliwalla, G. Karypis, P. M. Gaffney, W. A. Ortmann, K. J. Espe, K. B. Shark, W. J. Grande, K. M. Hughes, V. Kapur, P. K. Gregersen, and T. W. Behrens. 2003. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc. Natl. Acad. Sci. USA 100: 2610-2615. DOI ScienceOn |
47 |
Qin, H., X. Zhu, J. Liang, J. Wu, Y. Yang, S. Wang, W. Shi, and J. Xu. 2013. MicroRNA-29b contributes to DNA hypomethylation of |
48 | Dai, Y., Y. S. Huang, M. Tang, T. Y. Lv, C. X. Hu, Y. H. Tan, Z. M. Xu, and Y. B. Yin. 2007. Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients. Lupus 16: 939-946. DOI ScienceOn |
49 | Sheedy, F. J., E. Palsson-McDermott, E. J. Hennessy, C. Martin, J. J. O'Leary, Q. Ruan, D. S. Johnson, Y. Chen, and L. A. O'Neill. 2010. Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat. Immunol. 11: 141-147. DOI ScienceOn |
50 |
Ding, S., Y. Liang, M. Zhao, G. Liang, H. Long, S. Zhao, Y. Wang, H. Yin, P. Zhang, Q. Zhang, and Q. Lu. 2012. Decreased microRNA-142-3p/5p expression causes |
51 | Diaz, M. 2013. The role of activation-induced deaminase in lupus nephritis. Autoimmunity 46: 115-120. DOI ScienceOn |
52 | Cannons, J. L., H. Qi, K. T. Lu, M. Dutta, J. Gomez-Rodriguez, J. Cheng, E. K. Wakeland, R. N. Germain, and P. L. Schwartzberg. 2010. Optimal germinal center responses require a multistage T cell: B cell adhesion process involving integrins, SLAM-associated protein, and CD84. Immunity 32: 253-265. DOI ScienceOn |
53 | Komori, H., H. Furukawa, S. Mori, M. R. Ito, M. Terada, M. C. Zhang, N. Ishii, N. Sakuma, M. Nose, and M. Ono. 2006. A signal adaptor SLAM-associated protein regulates spontaneous autoimmunity and Fas-dependent lymphoproliferation in MRL-Faslpr lupus mice. J. Immunol. 176: 395-400. DOI |
54 | Zan, H. and P. Casali. 2013. Regulation of Aicda expression and AID activity. Autoimmunity 46: 83-101. DOI ScienceOn |
55 | Jiang, C., J. Foley, N. Clayton, G. Kissling, M. Jokinen, R. Herbert, and M. Diaz. 2007. Abrogation of lupus nephritis in activation-induced deaminase-deficient MRL/lpr mice. J. Immunol. 178: 7422-7431. DOI |
56 | Dorsett, Y., K. M. McBride, M. Jankovic, A. Gazumyan, T. H. Thai, D. F. Robbiani, M. Di Virgilio, B. Reina San-Martin, G. Heidkamp, T. A. Schwickert, T. Eisenreich, K. Rajewsky, and M. C. Nussenzweig. 2008. MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation. Immunity 28: 630-638. DOI ScienceOn |
57 | Xue, F., H. Li, J. Zhang, J. Lu, Y. Xia, and Q. Xia. 2013. miR-31 regulates interleukin 2 and kinase suppressor of ras 2 during T cell activation. Genes Immun. 14: 127-131. DOI ScienceOn |
58 | Helms, W. S., J. L. Jeffrey, D. A. Holmes, M. B. Townsend, N. A. Clipstone, and L. Su. 2007. Modulation of NFAT-dependent gene expression by the RhoA signaling pathway in T cells. J. Leukoc. Biol. 82: 361-369. DOI ScienceOn |
59 | Teng, G., P. Hakimpour, P. Landgraf, A. Rice, T. Tuschl, R. Casellas, and F. N. Papavasiliou. 2008. MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase. Immunity 28: 621-629. DOI ScienceOn |
60 | Richardson, B., L. Scheinbart, J. Strahler, L. Gross, S. Hanash, and M. Johnson. 1990. Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum. 33: 1665-1673. DOI ScienceOn |
61 | Jin, O., S. Kavikondala, M. Y. Mok, L. Sun, J. Gu, R. Fu, A. Chan, J. Yeung, Y. Nie, and C. S. Lau. 2010. Abnormalities in circulating plasmacytoid dendritic cells in patients with systemic lupus erythematosus. Arthritis Res. Ther. 12: R137. DOI |
62 | Rouas, R., H. Fayyad-Kazan, N. El Zein, P. Lewalle, F. Rothe, A. Simion, H. Akl, M. Mourtada, M. El Rifai, A. Burny, P. Romero, P. Martiat, and B. Badran. 2009. Human natural Treg microRNA signature: role of microRNA-31 and microRNA-21 in FOXP3 expression. Eur. J. Immunol. 39: 1608-1618. DOI ScienceOn |
63 | Zhao, X., Y. Tang, B. Qu, H. Cui, S. Wang, L. Wang, X. Luo, X. Huang, J. Li, S. Chen, and N. Shen. 2010. MicroRNA-125a contributes to elevated inflammatory chemokine RANTES levels via targeting KLF13 in systemic lupus erythematosus. Arthritis Rheum. 62: 3425-3435. DOI ScienceOn |
64 | Lu, M. M., J. Wang, H. F. Pan, G. M. Chen, J. Li, H. Cen, C. C. Feng, and D. Q. Ye. 2012. Increased serum RANTES in patients with systemic lupus erythematosus. Rheumatol. Int. 32: 1231-1233. DOI ScienceOn |
65 | Song, A., Y. F. Chen, K. Thamatrakoln, T. A. Storm, and A. M. Krensky. 1999. RFLAT-1: a new zinc finger transcription factor that activates RANTES gene expression in T lymphocytes. Immunity 10: 93-103. DOI ScienceOn |
66 | Liu, Y., J. Dong, R. Mu, Y. Gao, X. Tan, Y. Li, Z. Li, and G. Yang. 2013. MicroRNA-30a promotes B cell hyperactivity in patients with systemic lupus erythematosus by direct interaction with Lyn. Arthritis Rheum. 65: 1603-1611. DOI ScienceOn |
67 | Liossis, S. N., E. E. Solomou, M. A. Dimopoulos, P. Panayiotidis, M. M. Mavrikakis, and P. P. Sfikakis. 2001. B-cell kinase lyn deficiency in patients with systemic lupus erythematosus. J. Investig. Med. 49: 157-165. DOI |
68 | Flores-Borja, F., P. S. Kabouridis, E. C. Jury, D. A. Isenberg, and R. A. Mageed. 2005. Decreased Lyn expression and translocation to lipid raft signaling domains in B lymphocytes from patients with systemic lupus erythematosus. Arthritis Rheum. 52: 3955-3965. DOI ScienceOn |
69 | Luo, X., W. Yang, D. Q. Ye, H. Cui, Y. Zhang, N. Hirankarn, X. Qian, Y. Tang, Y. L. Lau, N. de Vries, P. P. Tak, B. P. Tsao, and N. Shen. 2011. A functional variant in microRNA-146a promoter modulates its expression and confers disease risk for systemic lupus erythematosus. PLoS Genet. 7: e1002128. DOI |
70 | Hou, J., P. Wang, L. Lin, X. Liu, F. Ma, H. An, Z. Wang, and X. Cao. 2009. MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2. J. Immunol. 183: 2150-2158. DOI ScienceOn |
71 | Karrich, J. J., L. C. Jachimowski, M. Libouban, A. Iyer, K. Brandwijk, E. W. Taanman-Kueter, M. Nagasawa, E. C. de Jong, C. H. Uittenbogaart, and B. Blom. 2013. MicroRNA-146a regulates survival and maturation of human plasmacytoid dendritic cells. Blood 122: 3001-3009. DOI ScienceOn |
72 | Chan, V. S., Y. J. Nie, N. Shen, S. Yan, M. Y. Mok, and C. S. Lau. 2012. Distinct roles of myeloid and plasmacytoid dendritic cells in systemic lupus erythematosus. Autoimmun. Rev. 11: 890-897. DOI ScienceOn |
73 | Jin, O., S. Kavikondala, L. Sun, R. Fu, M. Y. Mok, A. Chan, J. Yeung, and C. S. Lau. 2008. Systemic lupus erythematosus patients have increased number of circulating plasmacytoid dendritic cells, but decreased myeloid dendritic cells with deficient CD83 expression. Lupus 17: 654-662. DOI |
74 | Keller, A., P. Leidinger, A. Bauer, A. Elsharawy, J. Haas, C. Backes, A. Wendschlag, N. Giese, C. Tjaden, K. Ott, J. Werner, T. Hackert, K. Ruprecht, H. Huwer, J. Huebers, G. Jacobs, P. Rosenstiel, H. Dommisch, A. Schaefer, J. Muller-Quernheim, B. Wullich, B. Keck, N. Graf, J. Reichrath, B. Vogel, A. Nebel, S. U. Jager, P. Staehler, I. Amarantos, V. Boisguerin, C. Staehler, M. Beier, M. Scheffler, M. W. Buchler, J. Wischhusen, S. F. M. Haeusler, J. Dietl, S. Hofmann, H. P. Lenhof, S. Schreiber, H. A. Katus, W. Rottbauer, B. Meder, J. D. Hoheisel, A. Franke, and E. Meese. 2011. Toward the blood-borne miRNome of human diseases. Nat. Methods 8: 841-843. DOI ScienceOn |
75 | Su, X., C. Qian, Q. Zhang, J. Hou, Y. Gu, Y. Han, Y. Chen, M. Jiang, and X. Cao. 2013. miRNomes of haematopoietic stem cells and dendritic cells identify miR-30b as a regulator of Notch1. Nat. Commun. 4: 2903. |
76 | Yuan, Y., S. Kasar, C. Underbayev, D. Vollenweider, E. Salerno, S. V Kotenko, and E. Raveche. 2012. Role of microRNA-15a in autoantibody production in interferon- augmented murine model of lupus. Mol. Immunol. 52: 61-70. DOI ScienceOn |
77 | De Yebenes, V. G., L. Belver, D. G. Pisano, S. Gonzalez, A. Villasante, C. Croce, L. He, and A. R. Ramiro. 2008. miR-181b negatively regulates activation-induced cytidine deaminase in B cells. J. Exp. Med. 205: 2199-2206. DOI ScienceOn |
78 | Dai, R., Y. Zhang, D. Khan, B. Heid, D. Caudell, O. Crasta, and S. A. Ahmed. 2010. Identification of a common lupus disease-associated microRNA expression pattern in three different murine models of lupus. PLoS One 5: e14302. DOI ScienceOn |
79 | Thai, T. H., H. C. Patterson, D. H. Pham, K. Kis-Toth, D. A. Kaminski, and G. C. Tsokos. 2013. Deletion of microRNA-155 reduces autoantibody responses and alleviates lupus-like disease in the Fas(lpr) mouse. Proc. Natl. Acad. Sci. USA 110: 20194-20199. DOI ScienceOn |
80 | Pan, Y., T. Jia, Y. Zhang, K. Zhang, R. Zhang, J. Li, and L. Wang. 2012. MS2 VLP-based delivery of microRNA-146a inhibits autoantibody production in lupus-prone mice. Int. J. Nanomedicine 7: 5957-5967. |
81 | Garchow, B. G., O. Bartulos Encinas, Y. T. Leung, P. Y. Tsao, R. A. Eisenberg, R. Caricchio, S. Obad, A. Petri, S. Kauppinen, and M. Kiriakidou. 2011. Silencing of microRNA-21 in vivo ameliorates autoimmune splenomegaly in lupus mice. EMBO Mol. Med. 3: 605-615. DOI |
82 | Charrier, E., P. Cordeiro, M. Cordeau, R. Dardari, A. Michaud, M. Harnois, N. Merindol, S. Herblot, and M. Duval. 2012. Post-transcriptional down-regulation of Toll-like receptor signaling pathway in umbilical cord blood plasmacytoid dendritic cells. Cell. Immunol. 276: 114-121. DOI ScienceOn |
83 | Zhou, X., L. T. Jeker, B. T. Fife, S. Zhu, M. S. Anderson, M. T. McManus, and J. A. Bluestone. 2008. Selective miRNA disruption in T reg cells leads to uncontrolled autoimmunity. J. Exp. Med. 205: 1983-1991. DOI ScienceOn |
84 | Rahman, A., and D. A. Isenberg. 2008. Systemic lupus erythematosus. N. Engl. J. Med. 358: 929-939. DOI ScienceOn |
85 | Zhu, X., J. Liang, F. Li, Y. Yang, L. Xiang, and J. Xu. 2011. Analysis of associations between the patterns of global DNA hypomethylation and expression of DNA methyltransferase in patients with systemic lupus erythematosus. Int. J. Dermatol. 50: 697-704. DOI ScienceOn |
86 | Belver, L., V. G. de Yebenes, and A. R. Ramiro. 2010. MicroRNAs prevent the generation of autoreactive antibodies. Immunity 33: 713-722. DOI ScienceOn |
87 | Boldin, M. P., K. D. Taganov, D. S. Rao, L. Yang, J. L. Zhao, M. Kalwani, Y. Garcia-Flores, M. Luong, A. Devrekanli, J. Xu, G. Sun, J. Tay, P. S. Linsley, and D. Baltimore. 2011. miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. J. Exp. Med. 208: 1189-1201. DOI ScienceOn |
![]() |